We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Silence Therapeutics Plc | LSE:SLN | London | Ordinary Share | GB00B9GTXM62 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 535.00 | 521.00 | 524.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSLN
RNS Number : 1711D
Silence Therapeutics PLC
05 October 2018
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 1. Identity of the issuer or the underlying Silence Therapeutics issuer of existing shares to which voting rights are attached: (ii) ------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X ------------------------------------------------------------------------------ --------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------------------ --------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------------------ --------------------- An event changing the breakdown of voting rights ------------------------------------------------------------------------------ --------------------- Other (please specify): ------------------------------------------------------------------------- --- --------------------- 3. Full name of person(s) subject Ali Mortazavi to the notification obligation: (iii) ------------------------- 4. Full name of shareholder(s) Ali Mortazavi (if different from 3.):(iv) ------------------------- 5. Date of the transaction and date 04 October 2018 on which the threshold is crossed or reached: (v) ------------------------- 6. Date on which issuer notified: 05 October 2018 ------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 3%, 4% ------------------------- 8. Notified details: A: Voting rights attached to shares (viii, ix) Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE -------------------------------- --------------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights --------------- --------------- -------------- ----------------------- ---------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ----------- ----------- -------------- ---------- ----------- ------------ -------------- GB00B9GTXM62 1937399 1937399 2899184 2899184 4.08 --------------- --------------- -------------- ---------- ----------- ------------ -------------- B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of voting % of voting financial date (xiii) Conversion Period rights that may rights instrument (xiv) be acquired if the instrument is exercised/ converted. ------------- ------------------------------- ------------------------- ------------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) Resulting situation after the triggering transaction Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date (xvii) Conversion rights instrument (xix, xx) instrument period refers to (xviii) ------------- ------------- ---------------- ------------------------- -------------------------- Nominal Delta ------------- ------------- ---------------- ------------------------- ------------ ------------ Total (A+B+C) Number of voting rights Percentage of voting rights ------------------------------------------------------------------- 2899184 4.08 ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14. Contact name: ---- 15. Contact telephone number: ----
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLUVAORWRARRAA
(END) Dow Jones Newswires
October 05, 2018 09:16 ET (13:16 GMT)
1 Year Silence Therapeutics Chart |
1 Month Silence Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions